The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Update on the Autoimmune Pathology of Multiple Sclerosis: B-Cells as Disease-Drivers and Therapeutic Targets
Open accessAbstract
Background: Collectively, research on the role of B-cells in the pathogenesis of multiple sclerosis (MS) illustrates how translational medicine has given rise to promising therapeutic approaches for one of the most debilitating chronic neurological diseases in young adults. First described in 1935, the experimental autoimmune/allergic encephalomyelitis model is a key animal model that has provided the foundation for important developments in targeted therapeutics. Summary: While additional B-cell therapies for MS are presently being developed by the pharmaceutical industry, much remains to be understood about the role played by B-cells in MS. The goal of this review is to summarize how B-cells may contribute to MS pathogenesis and thereby provide a basis for understanding why B-cell depletion is so effective in the treatment of this disease. Key Messages: B-cells are key players in the pathogenesis of MS, and their depletion via B-cell-targeted therapy ameliorates disease activity. Clinical Implications: In 2008, data from the first CD20-targeting B-cell depleting therapeutic trials using rituximab in MS were published. Since then, there has been a large body of evidence demonstrating the effectiveness of B-cell depletion mediated via anti-CD20 antibodies. Intense research efforts focusing on the immunopathological relevance of B-cells has gained significant momentum and given rise to a constellation of promising therapeutic agents for this complex B-cell-driven disease, including novel anti-CD20 antibodies, as well as agents targeting CD19 and BAFF-R.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Compston, A., & Coles, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61620-7 · Cited by 4,372
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis
Hauser, S. L., Waubant, E., Arnold, D. L., Vollmer, T., Antel, J., Fox, R. J., Bar-Or, A., Panzara, M., Sarkar, N., Agarwal, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706383 · Cited by 2,439
Predominant Autoantibody Production by Early Human B Cell Precursors
Wardemann, H., Yurasov, S., Schaefer, A., Young, J. W., Meffre, E., & Nussenzweig, M. C. (2003) · Science · doi:10.1126/science.1086907 · Cited by 2,083
Blair, P. A., Noreña, L. Y., Flores-Borja, F., Rawlings, D. J., Isenberg, D. A., Ehrenstein, M. R., & Mauri, C. (2010) · Immunity · doi:10.1016/j.immuni.2009.11.009 · Cited by 1,574
The relation between inflammation and neurodegeneration in multiple sclerosis brains
Frischer, J. M., Bramow, S., Dal-Bianco, A., Lucchinetti, C. F., Rauschka, H., Schmidbauer, M., Laursen, H., Sorensen, P. S., & Lassmann, H. (2009) · Brain · doi:10.1093/brain/awp070 · Cited by 1,450
Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination
Berer, K., Mues, M., Koutrolos, M., Rasbi, Z. A., Boziki, M., Johner, C., Wekerle, H., & Krishnamoorthy, G. (2011) · Nature · doi:10.1038/nature10554 · Cited by 1,251
Serafini, B., Rosicarelli, B., Magliozzi, R., Stigliano, E., & Aloisi, F. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00049.x · Cited by 1,208
Iwata, Y., Matsushita, T., Horikawa, M., DiLillo, D. J., Yanaba, K., Venturi, G. M., Szabolcs, P. M., Bernstein, S. H., Magro, C. M., Williams, A. D., et al. (2011) · Blood · doi:10.1182/blood-2010-07-294249 · Cited by 1,104
Sex ratio of multiple sclerosis in Canada: a longitudinal study
Orton, S.-M., Herrera, B. M., Yee, I. M., Valdar, W., Ramagopalan, S. V., Sadovnick, A. D., & Ebers, G. C. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70581-6 · Cited by 921
Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
Matsushita, T., Yanaba, K., Bouaziz, J.-D., Fujimoto, M., & Tedder, T. F. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36030 · Cited by 913
Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis
Howell, O. W., Reeves, C. A., Nicholas, R., Carassiti, D., Radotra, B., Gentleman, S. M., Serafini, B., Aloisi, F., Roncaroli, F., Magliozzi, R., et al. (2011) · Brain · doi:10.1093/brain/awr182 · Cited by 858
Munn, D. H., Sharma, M. D., Hou, D., Baban, B., Lee, J. R., Antonia, S. J., Messina, J. L., Chandler, P., Koni, P. A., & Mellor, A. L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21583 · Cited by 852
The Neurobiology of Multiple Sclerosis: Genes, Inflammation, and Neurodegeneration
Hauser, S. L., & Oksenberg, J. R. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.011 · Cited by 776
A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis
Magliozzi, R., Howell, O. W., Reeves, C., Roncaroli, F., Nicholas, R., Serafini, B., Aloisi, F., & Reynolds, R. (2010) · Annals of Neurology · doi:10.1002/ana.22230 · Cited by 747
Kappos, L., Li, D., Calabresi, P. A., O'Connor, P., Bar-Or, A., Barkhof, F., Yin, M., Leppert, D., Glanzman, R., Tinbergen, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61649-8 · Cited by 743
Duddy, M., Niino, M., Adatia, F., Hebert, S., Freedman, M., Atkins, H., Kim, H. J., & Bar-Or, A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.10.6092 · Cited by 653
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells
Barr, T. A., Shen, P., Brown, S., Lampropoulou, V., Roch, T., Lawrie, S., Fan, B., O’Connor, R. A., Anderton, S. M., Bar-Or, A., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111675 · Cited by 649
Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions
Yoshizaki, A., Miyagaki, T., DiLillo, D. J., Matsushita, T., Horikawa, M., Kountikov, E. I., Spolski, R., Poe, J. C., Leonard, W. J., & Tedder, T. F. (2012) · Nature · doi:10.1038/nature11501 · Cited by 634
Krumbholz, M., Theil, D., Cepok, S., Hemmer, B., Kivisäkk, P., Ransohoff, R. M., Hofbauer, M., Farina, C., Derfuss, T., Hartle, C., et al. (2006) · Brain · doi:10.1093/brain/awh680 · Cited by 561
Leandro, M. J., Cambridge, G., Ehrenstein, M. R., & Edwards, J. C. W. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21617 · Cited by 560
Saadoun, S., Waters, P., Bell, B. A., Vincent, A., Verkman, A. S., & Papadopoulos, M. C. (2010) · Brain · doi:10.1093/brain/awp309 · Cited by 548
Importance of Cellular Microenvironment and Circulatory Dynamics in B Cell Immunotherapy
Gong, Q., Ou, Q., Ye, S., Lee, W. P., Cornelius, J., Diehl, L., Lin, W. Y., Hu, Z., Lu, Y., Chen, Y., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.817 · Cited by 543
Rituximab in relapsing‐remitting multiple sclerosis: A 72‐week, open‐label, phase I trial
Bar‐Or, A., Calabresi, P. A. J., Arnold, D., Markowitz, C., Shafer, S., Kasper, L. H., Waubant, E., Gazda, S., Fox, R. J., Panzara, M., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21363 · Cited by 527
Abnormal B‐cell cytokine responses a trigger of T‐cell–mediated disease in MS?
Bar‐Or, A., Fawaz, L., Fan, B., Darlington, P. J., Rieger, A., Ghorayeb, C., Calabresi, P. A., Waubant, E., Hauser, S. L., Zhang, J., et al. (2010) · Annals of Neurology · doi:10.1002/ana.21939 · Cited by 521
Ng, L. G., Sutherland, A. P. R., Newton, R., Qian, F., Cachero, T. G., Scott, M. L., Thompson, J. S., Wheway, J., Chtanova, T., Groom, J., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.807 · Cited by 500
Krumbholz, M., Theil, D., Derfuss, T., Rosenwald, A., Schrader, F., Monoranu, C.-M., Kalled, S. L., Hess, D. M., Serafini, B., Aloisi, F., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041674 · Cited by 492
Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients
Cross, A. H., Stark, J. L., Lauber, J., Ramsbottom, M. J., & Lyons, J.-A. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.06.029 · Cited by 454
B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes
Stern, J. N. H., Yaari, G., Vander Heiden, J. A., Church, G., Donahue, W. F., Hintzen, R. Q., Huttner, A. J., Laman, J. D., Nagra, R. M., Nylander, A., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008879 · Cited by 441
Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation
Mouquet, H., Scheid, J. F., Zoller, M. J., Krogsgaard, M., Ott, R. G., Shukair, S., Artyomov, M. N., Pietzsch, J., Connors, M., Pereyra, F., et al. (2010) · Nature · doi:10.1038/nature09385 · Cited by 427
Prospective study on the relationship between infections and multiple sclerosis exacerbations
Buljevac, D., Flach, H. Z., Hop, W. C. J., Hijdra, D., Laman, J. D., Savelkoul, H. F. J., van der Meché, F. G. A., van Doorn, P. A., & Hintzen, R. Q. (2002) · Brain · doi:10.1093/brain/awf098 · Cited by 427
Molnarfi, N., Schulze-Topphoff, U., Weber, M. S., Patarroyo, J. C., Prod’homme, T., Varrin-Doyer, M., Shetty, A., Linington, C., Slavin, A. J., Hidalgo, J., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130699 · Cited by 418
Self-citationSchluesener, H. J., Sobel, R. A., Linington, C., & Weiner, H. L. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.12.4016 · Cited by 371
Cepok, S., Rosche, B., Grummel, V., Vogel, F., Zhou, D., Sayn, J., Sommer, N., Hartung, H.-P., & Hemmer, B. (2005) · Brain · doi:10.1093/brain/awh486 · Cited by 367
Sasaki, Y., Casola, S., Kutok, J. L., Rajewsky, K., & Schmidt-Supprian, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.4.2245 · Cited by 365
Corcione, A., Casazza, S., Ferretti, E., Giunti, D., Zappia, E., Pistorio, A., Gambini, C., Mancardi, G. L., Uccelli, A., & Pistoia, V. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402455101 · Cited by 349
Roll, P., Palanichamy, A., Kneitz, C., Dorner, T., & Tony, H. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22019 · Cited by 321
Self-citationQin, Y., Duquette, P., Zhang, Y., Talbot, P., Poole, R., & Antel, J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3568 · Cited by 320
Weber, M. S., Prod'homme, T., Patarroyo, J. C., Molnarfi, N., Karnezis, T., Lehmann‐Horn, K., Danilenko, D. M., Eastham‐Anderson, J., Slavin, A. J., Linington, C., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22081 · Cited by 318
Self-citationMagliozzi, R., Columba-Cabezas, S., Serafini, B., & Aloisi, F. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.10.056 · Cited by 317
Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.
Genain, C. P., Nguyen, M. H., Letvin, N. L., Pearl, R., Davis, R. L., Adelman, M., Lees, M. B., Linington, C., & Hauser, S. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118368 · Cited by 314
B Cell Repertoire Diversity and Clonal Expansion in Multiple Sclerosis Brain Lesions
Baranzini, S. E., Jeong, M. C., Butunoi, C., Murray, R. S., Bernard, C. C. A., & Oksenberg, J. R. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.9.5133 · Cited by 294
Lyons, J.-A., San, M., Happ, M. P., & Cross, A. H. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199911)29:11<3432::aid-immu3432>3.0.co;2-2 · Cited by 292
Obermeier, B., Mentele, R., Malotka, J., Kellermann, J., Kümpfel, T., Wekerle, H., Lottspeich, F., Hohlfeld, R., & Dornmair, K. (2008) · Nature Medicine · doi:10.1038/nm1714 · Cited by 292
Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients
Palanichamy, A., Jahn, S., Nickles, D., Derstine, M., Abounasr, A., Hauser, S. L., Baranzini, S. E., Leppert, D., & von Büdingen, H.-C. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400118 · Cited by 289
Self-citationSafety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: A phase 2 study
Sorensen, P. S., Lisby, S., Grove, R., Derosier, F., Shackelford, S., Havrdova, E., Drulovic, J., & Filippi, M. (2014) · Neurology · doi:10.1212/wnl.0000000000000125 · Cited by 278
The risk of relapses in multiple sclerosis during systemic infections
Correale, J., Fiol, M., & Gilmore, W. (2006) · Neurology · doi:10.1212/01.wnl.0000233834.09743.3b · Cited by 256
Colombo, M., Dono, M., Gazzola, P., Roncella, S., Valetto, A., Chiorazzi, N., Mancardi, G. L., & Ferrarini, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2782 · Cited by 246
B cell exchange across the blood-brain barrier in multiple sclerosis
von Büdingen, H.-C., Kuo, T. C., Sirota, M., van Belle, C. J., Apeltsin, L., Glanville, J., Cree, B. A., Gourraud, P.-A., Schwartzburg, A., Huerta, G., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63842 · Cited by 239
Self-citationPalanichamy, A., Apeltsin, L., Kuo, T. C., Sirota, M., Wang, S., Pitts, S. J., Sundar, P. D., Telman, D., Zhao, L. Z., Derstine, M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008930 · Cited by 225
Self-citationRelated B cell clones populate the meninges and parenchyma of patients with multiple sclerosis
Lovato, L., Willis, S. N., Rodig, S. J., Caron, T., Almendinger, S. E., Howell, O. W., Reynolds, R., O’Connor, K. C., & Hafler, D. A. (2011) · Brain · doi:10.1093/brain/awq350 · Cited by 223
Owens, G. P., Ritchie, A. M., Burgoon, M. P., Williamson, R. A., Corboy, J. R., & Gilden, D. H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.5.2725 · Cited by 209
Cd20 (pan‐B cell) antigen is expressed at a low level on a subpopulation of human T lymphocytes
Hultin, L. E., Hausner, M. A., Hultin, P. M., & Giorgi, J. V. (1993) · Cytometry · doi:10.1002/cyto.990140212 · Cited by 204
CD19: a promising B cell target for rheumatoid arthritis
Tedder, T. F. (2009) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.184 · Cited by 187
Lyons, J.-A., Ramsbottom, M. J., & Cross, A. H. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200207)32:7<1905::aid-immu1905>3.0.co;2-l · Cited by 181
Specific peripheral B cell tolerance defects in patients with multiple sclerosis
Kinnunen, T., Chamberlain, N., Morbach, H., Cantaert, T., Lynch, M., Preston-Hurlburt, P., Herold, K. C., Hafler, D. A., O’Connor, K. C., & Meffre, E. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68775 · Cited by 164
Depletion of functionally active CD20+ T cells by rituximab treatment
Wilk, E., Witte, T., Marquardt, N., Horváth, T., Kalippke, K., Scholz, K., Wilke, N., Schmidt, R. E., & Jacobs, R. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24998 · Cited by 152
Intrathecal IgM synthesis predicts the onset of new relapses and a worse disease course in MS
Villar, L. M., Masjuán, J., González‐Porqué, P., Plaza, J. M., Sádaba, M. C., Quirós-Roldán, E., Bootello, A., & Alvarez‐Cermeño, J. C. (2002) · Neurology · doi:10.1212/wnl.59.4.555 · Cited by 148
Linington, C., Engelhardt, B., Kapócs, G., & Lassman, H. (1992) · Journal of Neuroimmunology · doi:10.1016/0165-5728(92)90136-9 · Cited by 145
B-Cell Depletion In Vitro and In Vivo with an Afucosylated Anti-CD19 Antibody
Herbst, R., Wang, Y., Gallagher, S., Mittereder, N., Kuta, E. G., Damschroder, M. M., Woods, R., Rowe, D. C., Cheng, L., Cook, K., et al. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.168062 · Cited by 141
Obermeier, B., Lovato, L., Mentele, R., Brück, W., Forné, I., Imhof, A., Lottspeich, F., Turk, K. W., Willis, S. N., Wekerle, H., et al. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.01.010 · Cited by 139
Bar‐Or, A., de Oliveira, E. M. L., Anderson, D. E., Krieger, J. I., Duddy, M., O’Connor, K. C., & Hafler, D. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.5669 · Cited by 138
Atacicept: targeting B cells in multiple sclerosis
Hartung, H., & Kieseier, B. C. (2010) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285610371146 · Cited by 129
Oligoclonal IgG Bands in Cerebrospinal Fluid
Kostulas, V. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520220043014 · Cited by 119
New Anti-CD20 Monoclonal Antibodies for the Treatment of B-Cell Lymphoid Malignancies
Robak, T., & Robak, E. (2010) · BioDrugs · doi:10.2165/11539590-000000000-00000 · Cited by 118
Harp, C. T., Ireland, S. J., Davis, L. S., Remington, G. M., Cassidy, B., Cravens, P. D., Stüve, O., Lovett‐Racke, A. E., Eagar, T. N., Greenberg, B. M., et al. (2010) · European Journal of Immunology · doi:10.1002/eji.201040516 · Cited by 117
Yazawa, N., Hamaguchi, Y., Poe, J. C., & Tedder, T. F. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505539102 · Cited by 115
In multiple sclerosis, oligoclonal bands connect to peripheral B‐cell responses
Bankoti, J., Apeltsin, L., Hauser, S. L., Allen, S., Albertolle, M. E., Witkowska, H. E., & von Büdingen, H. ‐. (2013) · Annals of Neurology · doi:10.1002/ana.24088 · Cited by 92
Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders
Lehmann‐Horn, K., Schleich, E., Hertzenberg, D., Hapfelmeier, A., Kümpfel, T., von Bubnoff, N. C. C., Hohlfeld, R., Berthele, A., Hemmer, B., & Weber, M. S. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-146 · Cited by 90
Self-citationSmith‐Jensen, T., Burgoon, M. P., Anthony, J., Kraus, H. L., Gilden, D. H., & Owens, G. P. (2000) · Neurology · doi:10.1212/wnl.54.6.1227 · Cited by 87
Intrathecal somatic hypermutation of IgM in multiple sclerosis and neuroinflammation
Beltrán, E., Obermeier, B., Moser, M., Coret, F., Simó, M., Boscá, I., Miralles, F. C. P., Villar, L. M., Şenel, M., Tumani, H., et al. (2014) · Brain · doi:10.1093/brain/awu205 · Cited by 84
Ritchie, A. M., Gilden, D. H., Williamson, R. A., Burgoon, M. P., Yu, X., Helm, K. M., Corboy, J. R., & Owens, G. P. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.649 · Cited by 78
B cells undergo unique compartmentalized redistribution in multiple sclerosis
Haas, J., Bekeredjian‐Ding, I., Milkova, M., Balint, B., Schwarz, A., Korporal, M., Jarius, S., Fritz, B., Lorenz, H., & Wildemann, B. (2011) · Journal of Autoimmunity · doi:10.1016/j.jaut.2011.08.003 · Cited by 76
Eggleton, P., Bremer, E., Tarr, J. M., de Bruyn, M., Helfrich, W., Kendall, A. C., Haigh, R. C., Viner, N. J., & Winyard, P. G. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3541 · Cited by 75
Sandberg‐Wollheim, M., & Turesson, I. (1975) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1975.tb03724.x · Cited by 65
von Büdingen, H. ‐., Gulati, M., Kuenzle, S., Fischer, K., Rupprecht, T. A., & Goebels, N. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.10.005 · Cited by 54
Accelerated central nervous system autoimmunity in BAFF-receptor-deficient mice
Kim, S. S., Richman, D. P., Zamvil, S. S., & Agius, M. A. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.04.008 · Cited by 28
Self-citationThe potential risk of infections during (prolonged) rituximab therapy in rheumatoid arthritis
Brinkman, I., van de Laar, M. A. F. J., Jansen, T., & van Roon, E. N. (2011) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2011.562188 · Cited by 18
Diagnostic criteria for primary progressive mutiple sclerosis: a position paper.
(2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200006)47:6 · Cited by 2
Cited by
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
Lennon, V. A., Kryzer, T. J., Pittock, S. J., Verkman, A. S., & Hinson, S. R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050304 · Cited by 2,288
Traumatic Spinal Cord Injury: An Overview of Pathophysiology, Models and Acute Injury Mechanisms
Alizadeh, A., Dyck, S. M., & Karimi-Abdolrezaee, S. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00282 · Cited by 1,407
A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica
Lucchinetti, C. F. (2002) · Brain · doi:10.1093/brain/awf151 · Cited by 1,210
The Immunopathology of Multiple Sclerosis: An Overview
Lassmann, H., Brück, W., & Lucchinetti, C. F. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00064.x · Cited by 1,182
Progressive multiple sclerosis: pathology and pathogenesis
Lassmann, H., van Horssen, J., & Mahad, D. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.168 · Cited by 1,033
Metadata
- Authors
- von Büdingen, H.-C., Palanichamy, A., Lehmann-Horn, K., Michel, B. A., & Zamvil, S. S.
- Venue
- European Neurology
- Publisher
- S. Karger AG
- Published
- 2015
- Volume
- 73
- Issue
- 3-4
- Pages
- 238-246
- ISSN
- 0014-3022 (ISSN-L)
- 1421-9913
- OpenAlex
- W2086080135
- Cited by
- 1,463
- References
- 78
- FWCI
- 113.57
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.